Palmrich, P.; Schirwani-Hartl, N.; Haberl, C.; Haslinger, P.; Heinzl, F.; Zeisler, H.; Binder, J.
Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies. J. Clin. Med. 2023, 12, 5931.
https://doi.org/10.3390/jcm12185931
AMA Style
Palmrich P, Schirwani-Hartl N, Haberl C, Haslinger P, Heinzl F, Zeisler H, Binder J.
Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies. Journal of Clinical Medicine. 2023; 12(18):5931.
https://doi.org/10.3390/jcm12185931
Chicago/Turabian Style
Palmrich, Pilar, Nawa Schirwani-Hartl, Christina Haberl, Peter Haslinger, Florian Heinzl, Harald Zeisler, and Julia Binder.
2023. "Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies" Journal of Clinical Medicine 12, no. 18: 5931.
https://doi.org/10.3390/jcm12185931
APA Style
Palmrich, P., Schirwani-Hartl, N., Haberl, C., Haslinger, P., Heinzl, F., Zeisler, H., & Binder, J.
(2023). Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies. Journal of Clinical Medicine, 12(18), 5931.
https://doi.org/10.3390/jcm12185931
